Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS)...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is overvalued on P/FCF.
Target Price
The average target price of ATLN is 6.0 and suggests 79% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell